217 results on '"A. González-Martin"'
Search Results
2. Oral squamous cell carcinomas drive monocytes into immunosuppressive CD25+CD163+CD206+ macrophages
3. Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial
4. Predicting benefit from PARP inhibitors using deep learning on H&E-stained ovarian cancer slides
5. Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial
6. Improving the adhesion of satin XPS to sandstone with customized polyurethane adhesives for sustainable facade cladding and thermal insulation
7. Multi-channel capillary bioreactor for hydrophobic VOC and CO2 abatement – Process intensification through silicone oil addition
8. Tolerability of the niraparib individualized starting dose in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy
9. Colorectal cancer recurrence and its impact on survival after curative surgery: An analysis based on multistate models
10. Diffusion assisted image reconstruction in optoacoustic tomography
11. Clinical evaluation of a low-coverage whole-genome test for detecting homologous recombination deficiency in ovarian cancer
12. ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease
13. Indoor air VOCs biofiltration by bioactive coating packed bed bioreactors
14. Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup
15. Metal-free organocatalysts for high hydrolytic stability single component polyurethane adhesives and their application in decorative insulation facades manufacturing
16. Hydrophobic air pollutants removal at one second gas contact in a multi-channel capillary bioreactor
17. A systematic review and meta-analysis on the efficacy of topical povidone iodine in adenoviral conjunctivitis
18. Hindfoot motion through helical axis image-based on dynamic CT scan using an original simulated weightbearing device
19. Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
20. PLA-Mg film degradation under in vitro environments supplemented with glucose and/or ketone bodies
21. Progression-free survival and safety at 3.5 years of follow-up: results from the randomised phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer
22. Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial
23. PARP inhibitor predictive value of the Leuven HRD test compared with Myriad MyChoice CDx PLUS HRD on 468 ovarian cancer patients from the PAOLA-1/ENGOT-ov25 trial
24. Inactivation efficacy and reactivation of fecal bacteria with a flow-through LED ultraviolet reactor: Intraspecific response prevails over interspecific differences
25. Combining band-frequency separation and deep neural networks for optoacoustic imaging
26. Real-world safety and effectiveness of maintenance niraparib for platinum-sensitive recurrent ovarian cancer: A GEICO retrospective observational study within the Spanish expanded-access programme
27. Continuous production of honey oligosaccharides in packed-bed reactors with immobilized α-glucosidase from Metschnikowia reukaufii
28. Antimicrobial resistance patterns of bacteria isolated from chicks of Canarian Egyptian vultures (Neophron percnopterus majorensis): A “one health” problem?
29. Secondary wastewater effluent treatment by microalgal-bacterial membrane photobioreactor at long solid retention times
30. Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial
31. Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter study
32. Maintenance olaparib plus bevacizumab in patients with newly diagnosed advanced high-grade ovarian cancer: Main analysis of second progression-free survival in the phase III PAOLA-1/ENGOT-ov25 trial
33. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial
34. Real-time embedded eye detection system
35. Integration of immunotherapy into treatment of cervical cancer: Recent data and ongoing trials
36. European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer
37. New Sub-Classification of Vancouver B2 Periprosthetic Hip Fractures According to Fracture Pattern
38. Optimization of acrylic-styrene latex-based biofilms as a platform for biological indoor air treatment
39. Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial
40. The role of the tumor primary chemosensitivity relative to the success of the medical-surgical management in patients with advanced ovarian carcinomas
41. Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication
42. c-Abl regulates a synaptic plasticity-related transcriptional program involved in memory and learning
43. Olaparib in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer regardless of BRCA status: a GEICO phase II trial (ROLANDO study)
44. Undernutrition induces major alterations in the lipid droplets of white and brown adipose tissues in wistar rats
45. The systemic treatment of recurrent ovarian cancer revisited
46. Clusterin overexpression as a potential neuroprotective response to the pathological effects of high fat dieting on the brain reward system
47. Patient-centred outcomes and effect of disease progression on health status in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation receiving maintenance olaparib or placebo (SOLO1): a randomised, phase 3 trial
48. Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study
49. Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial
50. Effect of plasma treatment on the surface properties of polylactic acid films
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.